Skip to content
healthcare.dev

FLUZONE HIGH DOSE NORTHERN HEMISPHERE

NDC 49281-126, INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (A/MISSOURI/11/2025 PDM09-LIKE VIRUS) (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED), injection, suspension, from Sanofi Vaccines US Inc..

Product NDC
49281-126
Status
Listed
Labeler
Sanofi Vaccines US Inc.
Dosage form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Product type
VACCINE
Marketing category
BLA
Application
BLA103914
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49281-126 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)60 ug/.5mL
  • INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)60 ug/.5mL
  • INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED)60 ug/.5mL
Package NDCNDC-11Package
49281-126-65492810126655 SYRINGE, GLASS in 1 PACKAGE (49281-126-65) / .5 mL in 1 SYRINGE, GLASS (49281-126-88)

Linked data

RxNorm, label and prices

Use it

Look up 49281-126 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49281-126 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49281-126. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.